Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 3Recurrence 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Transanal Endoscopic Surgery × Gastrointestinal × Clear all
NCT03959839 2025-06-03

DSETAMIS2018

Puerta de Hierro University Hospital

Phase NA Completed
70 enrolled
Gastrointestinal

Rectal Neoplasms, Recurrence

NCT01340755 2017-09-06

Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer

Massachusetts General Hospital

Phase NA Completed
5 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02626728 2016-11-22

TAMIS

Hvidovre University Hospital

Completed
25 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡